Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Personalized Medicine
|
May 20, 2018
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen
Nigel Fleeman, Katherine Payne, William G Newman, et al.
International Journal of Geriatric Psychiatry
|
January 23, 2018
A systematic review of the diagnostic accuracy of automated tests for cognitive impairment
Rabeea'h W Aslam, Vickie Bates, Yenal Dundar, et al.
Health Technology Assessment (Winchester, England)
|
April 26, 2016
The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
Nigel Fleeman, James Mahon, Vickie Bates, et al.
Health Technology Assessment (Winchester, England)
|
July 3, 2015
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation
Janette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Health Technology Assessment (Winchester, England)
|
October 22, 2016
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review
Rabeea'h W Aslam, Vickie Bates, Yenal Dundar, et al.
BMC Health Services Research
|
May 13, 2020
Engaging with stakeholders to inform the development of a decision-support tool for the NHS health check programme: qualitative study
Lirije Hyseni, Maria Guzman-Castillo, Chris Kypridemos, et al.
Database : the Journal of Biological Databases and Curation
|
May 19, 2016
A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
Gurpreet S Ghattaoraya, Yenal Dundar, Faviel F González-Galarza, et al.
Applied Health Economics and Health Policy
|
May 30, 2018
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
Rumona Dickson, Angela Boland, Rui Duarte, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Personalized Medicine
|
May 20, 2018
Are health technology assessments of pharmacogenetic tests feasible? A case study of CYP2D6 testing in the treatment of breast cancer with tamoxifen
Nigel Fleeman, Katherine Payne, William G Newman, et al.
International Journal of Geriatric Psychiatry
|
January 23, 2018
A systematic review of the diagnostic accuracy of automated tests for cognitive impairment
Rabeea'h W Aslam, Vickie Bates, Yenal Dundar, et al.
Health Technology Assessment (Winchester, England)
|
April 26, 2016
The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
Nigel Fleeman, James Mahon, Vickie Bates, et al.
Health Technology Assessment (Winchester, England)
|
July 3, 2015
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation
Janette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Health Technology Assessment (Winchester, England)
|
October 22, 2016
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review
Rabeea'h W Aslam, Vickie Bates, Yenal Dundar, et al.
BMC Health Services Research
|
May 13, 2020
Engaging with stakeholders to inform the development of a decision-support tool for the NHS health check programme: qualitative study
Lirije Hyseni, Maria Guzman-Castillo, Chris Kypridemos, et al.
Database : the Journal of Biological Databases and Curation
|
May 19, 2016
A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
Gurpreet S Ghattaoraya, Yenal Dundar, Faviel F González-Galarza, et al.
Applied Health Economics and Health Policy
|
May 30, 2018
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
Rumona Dickson, Angela Boland, Rui Duarte, et al.
Page
of 4